News About: Pharm. Industry
Viread took a step faster on the drug price reduction
‘Viread(generic name: tenofovir),’ a chronic type B hepatitis treatment, will took a step faster than ‘Baraclude(generic name: entecavir),’ which will face patent expiration on the coming October, on the drug price re...
Listed pharmaceutical companies eared KRW 71 by selling a KRW 1,000 product
It was analyzed that listed pharmaceutical companies earned KRW 71 from selling a product(including manufactured goods) worth of KRW 1,000 in the first quarter of the year.
According to the analysis result of KOSPI a...
Director Young-rae Song to be the chief of the Sanofi’s consumer healthcare departmentSanofi-Aventis Korea, a domestic affiliated company of Sanofi Group, announced on the 20th it has recruited Director Young-rae Song as a chief of its domestic consumer healthcar...
|
Listed pharmaceutical companies states “Reduction of sales management expenses was led to profitability improvement”
It is analyzed that listed pharmaceutical companies’ expense control on sales management has been lead to profitability.
According to the YakupDotCom’s analysis result of KOSPI and KOSDAQ listed pharmaceutical compan...
12 pharmaceutical companies making over KRW 10 billion annual investment occupied 75% of the entire investment
The centerpiece of the pharmaceutical industry is new drug development, and power of the new drug development comes from research and development(R&D). A new drug not only play a savior role for pharmaceutical compani...
The first half’s sales performance of listed pharmaceutical company was ‘Good’
Despite various policy restrictions and the MERS crisis, it is analyzed that listed pharmaceutical companies made decent sales and profits in the first half of the year.
According to the YakupDotCom’s analysis result...
Ahngook Pharm enters the Cialis market with the ‘OD!FS Technology’ for the first time in the worldWhile a generic war has been anticipated due to the patent expiration of Cialis(tadalafil), a impotency drug, on the coming September, Ahngook Pharm will enter the impotency tre...
|
Will the second SGLT-2 insurance benefit decision form competition against DPP-4?
For the second time in the domestic market, a SGLT-2inhibitor is going to receive the health insurance from the 1st. The benefited drug is ‘Suglat(generic name: ipragliflozin). Its insured drug price will be KRW 705 p...
Despite MERS sales of listed pharmaceutical companies increased 10% up in the 2nd quarter
Despite the Middle East Respiratory Syndrome, which struck Korea in the 2nd quarter of the year, sales of listed pharmaceutical companies are assessed to be decent.
According to the analysis result of sales reports o...
Laboratory Sinfa established a partnership contract with the Boehringer Ingelheim Korea’s OTC departmentLaboratori Sinfa(President Joo-cheol Lee), a Spanish pharmaceutical company, will expand its business into the medical device industry through the strategically partnership cont...
|
.jpg)
